Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Vaccines

Free Subscription 20.04.2026 3 BMJ 3 Clin Infect Dis 1 Infect Immun 1 J Immunol 1 J Virol 2 JAMA 2 Lancet 1 PLoS Comput Biol 3 PLoS One 1 Proc Natl Acad Sci U S A 23 Vaccine 3 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. O'DOWD A
   Covid vaccine rollout was "extraordinary," but payouts to people harmed should rise, says UK inquiry.
   BMJ. 2026;393:s729.
   PubMed        
   
   
2. DAVIES SR, Davies AL, Higgins JPT, Caldwell DM, et al
   Effectiveness of interventions to increase vaccine uptake: component network meta-analysis.
   BMJ. 2026;393:e087578.
   PubMed         Abstract available
   
   
3. SINGH M, Joshi S, Vohra V, Sarin R, et al
   Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial).
   BMJ. 2026;393:e085716.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

4. TUITE AR, Warshawsky BF, Friedman L, Kwong JC, et al
   Vaccine Performance Helps Explain Heterogeneity in Indirect Protection Across Influenza Vaccine Trials.
   Clin Infect Dis. 2026 Apr 17:ciag260. doi: 10.1093.
   PubMed        
   
   
5. LEROUX-ROELS I, Lins M, Surowitz R, Pragalos A, et al
   Immunogenicity and safety of co-administration of adjuvanted respiratory syncytial virus prefusion F protein vaccine with 20-valent pneumococcal conjugate vaccine in adults aged >/=60 years: a randomized, non-inferiority trial.
   Clin Infect Dis. 2026 Apr 13:ciag250. doi: 10.1093.
   PubMed         Abstract available
   
   
6. REIMER JENSEN AM, Johansen ND, Wolff PS, Vaduganathan M, et al
   Electronic Nudges to Increase Influenza Vaccination in Immunosuppressed Adults Across the Age Spectrum: A Pooled Analysis of Two Nationwide Randomized Trials.
   Clin Infect Dis. 2026 Apr 12:ciag219. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Infect Immun

7. LIU Z, Li C, Mahan S, Ren J, et al
   The oral vaccine intrOv is attenuated in infecting the lower airway and inducing chronic pathology.
   Infect Immun. 2026 Apr 15:e0012226. doi: 10.1128/iai.00122.
   PubMed         Abstract available
   
   

   
   J Immunol

8. BISWAS S, Howlader DR, Dietz Z, Halder P, et al
   Effectiveness and immunogenicity of a nanoemulsion protein subunit vaccine against Pseudomonas aeruginosa: investigation in diet-induced obese mice.
   J Immunol. 2026;215:vkag052.
   PubMed         Abstract available
   
   

   
   J Virol

9. TANG PCH, Ling Z, Lee M, King NJC, et al
   Combating respiratory diseases with mucosal vaccines.
   J Virol. 2026 Apr 15:e0014626. doi: 10.1128/jvi.00146.
   PubMed         Abstract available
   
   

   
   JAMA

10. RUBIN R
    How mRNA Vaccines Could Help Treat Cancer.
    JAMA. 2026 Apr 10. doi: 10.1001/jama.2026.2088.
    PubMed        
    
    
11. ABBASI J
    PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC.
    JAMA. 2026 Apr 10. doi: 10.1001/jama.2026.2399.
    PubMed        
    
    

    
    Lancet

12. JOHANSEN ND, Seco JP, Martinon-Torres F, Biering-Sorensen T, et al
    Unclear benefits of higher doses of influenza vaccine - Authors' reply.
    Lancet. 2026;407:1426.
    PubMed        
    
    
13. FLAHAULT A
    Unclear benefits of higher doses of influenza vaccine.
    Lancet. 2026;407:1425-1426.
    PubMed        
    
    

    
    PLoS Comput Biol

14. ANOKYE F, Li MWZ, Walker S, Hurford A, et al
    Quantifying SARS-CoV-2 Omicron variant spread and the impact of non-pharmaceutical interventions in Newfoundland and Labrador, Canada.
    PLoS Comput Biol. 2026;22:e1013562.
    PubMed         Abstract available
    
    

    
    PLoS One

15. AZIZ AB, Ahmmed F, Haile K, Kering K, et al
    Risk factors for spontaneous abortion following hepatitis E vaccination during and shortly before pregnancy: Further analysis from a cluster-randomized trial.
    PLoS One. 2026;21:e0345974.
    PubMed         Abstract available
    
    
16. MURALIDHAR K, Ngaybe MGB, Pope B, Nanjaiah S, et al
    Behavioural and Social Drivers (BeSD) of COVID-19 vaccination for children: A cross-sectional study of parental vaccine confidence and intent in Mysore, India.
    PLoS One. 2026;21:e0316877.
    PubMed         Abstract available
    
    
17. BERBER E, Hanley HB, Gamez BM, Ross TM, et al
    Assessment of hemagglutinin-inhibition activity following influenza vaccination during the 2022-2023, 2023-2024, and 2024-2025 seasons.
    PLoS One. 2026;21:e0347314.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

18. WELLS CR, Pandey A, Ye Y, Bawden C, et al
    The health and economic repercussions of declining MMR coverage in the United States.
    Proc Natl Acad Sci U S A. 2026;123:e2605971123.
    PubMed         Abstract available
    
    

    
    Vaccine

19. WU JD, Meng H, Guo XL, Liu L, et al
    The immune response of the mRNA vaccine CS-2034 as a heterologous booster before and after breakthrough infection: A follow-up study.
    Vaccine. 2026;81:128575.
    PubMed         Abstract available
    
    
20. MORELLI F, Augard C, Bourhy H, Bravo C, et al
    Factors influencing rabies vaccines immunogenicity during post-exposure prophylaxis: a systematic literature search and meta-analysis.
    Vaccine. 2026;81:128578.
    PubMed         Abstract available
    
    
21. ANYALECHI EG, Marquez PL, Rubin MN, Johannsen SP, et al
    Safety of seasonal inactivated influenza vaccines in children 6 months-17 years of age in the Vaccine Adverse Events Reporting System (VAERS) 2018-2023: before, during, and after the COVID-19 pandemic public health emergency.
    Vaccine. 2026;81:128569.
    PubMed         Abstract available
    
    
22. PITTET LF, Casalaz D, Donath S, Gardiner K, et al
    Effect of neonatal BCG vaccination on oral herpes in early childhood: A nested study within a randomised controlled trial.
    Vaccine. 2026;81:128577.
    PubMed         Abstract available
    
    
23. DE AGUIAR GB, da Costa MG, Garcia JH, Jacobs GB, et al
    Effects of candidate vaccines against Zika virus infection: A systematic review of the clinical trials.
    Vaccine. 2026;81:128562.
    PubMed         Abstract available
    
    
24. HSIEH SM, Choi MJ, Chen YC, Cheng SY, et al
    Cost-effectiveness of vaccination of older adults with an MF59(R)-adjuvanted quadrivalent influenza vaccine compared to standard-dose and high-dose vaccines in South Korea and Taiwan.
    Vaccine. 2026;80:128533.
    PubMed         Abstract available
    
    
25. MCCALL KL, Park JH, Clark TM, Steinberg JD, et al
    Pharmacovigilance analysis of vaccination errors during pregnancy using VAERS data.
    Vaccine. 2026;81:128570.
    PubMed         Abstract available
    
    
26. STIEHL E, Negrete M, Flores G, Federmeyer L, et al
    Empowering communities during the COVID-19 pandemic: insights from trusted messengers about their work addressing COVID-19 vaccine hesitancy.
    Vaccine. 2026;60 Suppl 1:128559.
    PubMed         Abstract available
    
    
27. HAVERKATE MR, van de Kassteele J, van den Hof S, Sanders JG, et al
    The effect of pre-booked appointments on COVID-19 vaccine uptake among previously vaccinated older adults during the 2023 autumn campaign in the Netherlands: a regression discontinuity analysis.
    Vaccine. 2026;81:128565.
    PubMed         Abstract available
    
    
28. XU MA, Pant S, DiClemente RJ
    Factors affecting human papillomavirus vaccination: A review of individual, interpersonal, and structural factors affecting vaccine uptake among adolescents.
    Vaccine. 2026;81:128563.
    PubMed         Abstract available
    
    
29. GASHEMA P, Iradukunda PG, Rudacogora JC, Siddig EE, et al
    Unlocking Africa's vaccine Independence: The critical role of technology transfer and intellectual property.
    Vaccine. 2026;81:128573.
    PubMed         Abstract available
    
    
30. OLSON NL, Mitchell PG, Armon C, Todd JK, et al
    Social vulnerability is associated with higher rate of emergency department visits and hospitalizations with vaccine preventable diseases among Colorado children.
    Vaccine. 2026;81:128585.
    PubMed         Abstract available
    
    
31. GATWOOD J, Zhu Y, Steffens A, Gallagher S, et al
    Missed opportunities for herpes zoster vaccination among older adults in the United States.
    Vaccine. 2026;79:128450.
    PubMed         Abstract available
    
    
32. MAUDONNET B, Silveira C, Cecatti JG, Costa ML, et al
    Factors associated with the use of COVID-19 vaccine during pregnancy: evidence from a multicenter Brazilian cross-sectional study.
    Vaccine. 2026 Apr 10:128549. doi: 10.1016/j.vaccine.2026.128549.
    PubMed         Abstract available
    
    
33. ZOU Z, Zhang H, Wang X, Zhao K, et al
    Potential benefits of optimised varicella vaccination scenarios in a western Chinese province: a modelling study using real-world data.
    Vaccine. 2026;81:128587.
    PubMed         Abstract available
    
    
34. KAPELUS DJ, Ranchod H, Olwagen CP, Koen A, et al
    Waning of measles immunity by 5 years of age following an accelerated two-dose measles vaccine schedule at 6 and 12 months in South African children: an observational cohort study.
    Vaccine. 2026;81:128580.
    PubMed         Abstract available
    
    
35. BROWN NE, Pawloski LC, Winter K, Harriman K, et al
    Longitudinal assessment of asymptomatic infection of Bordetella pertussis among pertussis acellular vaccinated adolescents.
    Vaccine. 2026;81:128567.
    PubMed         Abstract available
    
    
36. HIGGINS RA, Mazarakis N, Sun C, Toh ZQ, et al
    Effect of time-of-day vaccination on the antibody response to mRNA and protein COVID-19 vaccine in adults.
    Vaccine. 2026;81:128574.
    PubMed         Abstract available
    
    
37. IBE I, Palommella V, Chilton B, Malloy N, et al
    Barriers to adult vaccination: Findings from a national survey of healthcare professionals.
    Vaccine. 2026;81:128542.
    PubMed         Abstract available
    
    
38. SMET J, Smits K, Dirix V, Vermeulen F, et al
    Multiparametric analysis of vaccine-induced B and T cell responses for optimal evaluation of memory immune responses to Bordetella pertussis in children.
    Vaccine. 2026;81:128552.
    PubMed         Abstract available
    
    
39. CERVELLERA F, Vecchio R, Muzzi A, Bruno R, et al
    Strengthening hospital-based vaccination models for high-risk subjects: from evidence to implementation.
    Vaccine. 2026;81:128572.
    PubMed        
    
    
40. HIRAKAWA T, Yamada G, Tokiya M, Furukawa T, et al
    Impact of pre-vaccination active vitamin D levels on COVID-19 mRNA vaccine-induced immunity in a Japanese cohort.
    Vaccine. 2026;81:128576.
    PubMed         Abstract available
    
    
41. KARKI I, Pro G, Bhochhibhoya S, Teeter B, et al
    Social determinants of health associated with human papillomavirus vaccine uptake among teens.
    Vaccine. 2026;81:128586.
    PubMed         Abstract available
    
    

    
    Virology

42. ULLAH SHAH A, Rafique S, Peddireddi L, Wood B, et al
    Genomic characterization of some infectious laryngotracheitis virus (ILTV) field isolates from vaccinated chicken farms reveals evidence of vaccine-related genetic drift.
    Virology. 2026;620:110900.
    PubMed         Abstract available
    
    
43. WANG Z, Wongnak R, Oba M, Mizutani T, et al
    Omicron RBD expressed in E. coli outperforms mammalian-expressed S1 spike protein in generating highly neutralizing anti-SARS-CoV-2 antibodies in mice.
    Virology. 2026;619:110894.
    PubMed         Abstract available
    
    
44. RAMUTH M, Sonoo J, Pyndiah N, Rughooputh S, et al
    Epidemiology of influenza A and B viruses in Mauritius over an 8-year period, 2009-2016.
    Virology. 2026;619:110892.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum